Imatinib Mesylate (Gleevec) in the Treatment of Systemic Sclerosis
Clinical trial NCT00555581 · COMPLETED
Trial details
- NCT number
- NCT00555581
- Sponsor
- Hospital for Special Surgery, New York
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2011-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.